U.S. market Closed. Opens in 3 hours 26 minutes

SUPN | Supernus Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
Revenue607.52M667.24M579.77M520.40M392.75M408.90M302.24M215.00M144.43M122.05M12.02M1.48M803.00K106.00K37.92M8.89M4.23M
Cost of Revenue83.78M87.22M75.06M52.46M16.66M15.36M15.21M11.99M8.42M5.76M1.10MN/AN/A-13.40M-8.59M336.00N/A
Gross Profit523.74M580.02M504.71M467.94M376.10M393.54M287.02M203.02M136.00M116.29M10.91M1.48M803.00K13.51M46.51M8.89M4.23M
Operating Expenses529.01M534.40M425.21M292.34M227.52M249.10M187.48M148.80M118.34M92.06M72.83M43.65M38.55M40.23M33.91M34.75M23.28M
Selling, General & Admin336.36M377.22M304.76M200.68M158.43M159.89M137.91M106.01M89.20M72.47M55.59M20.13M7.93M5.08M4.65M4.29M4.01M
Research & Development91.59M74.55M90.47M75.96M69.10M89.21M49.58M42.79M29.14M19.59M17.25M23.52M30.63M35.15M29.26M30.46M19.27M
Other Operating Expenses101.06M82.63M29.99M15.70MN/AN/AN/A-15.00K38.00K39.00K101.00K-660.00K117.00K542.00KN/AN/AN/A
Operating Income-5.27M67.30M86.03M173.70M148.57M144.44M99.54M54.22M17.66M24.23M-61.92M-42.17M-37.75M-40.12M4.02M-25.86M-19.05M
Other Expenses / Income8.04M14.62M-12.85M-5.05M-1.08M-4.27M1.08M-3.85M-6.23M-4.36M-30.35M-4.12M-1.72M649.00K122.00K-7.62M1.77M
Before Tax Income2.77M60.74M73.17M168.65M147.49M140.18M100.62M50.37M14.97M19.87M-92.27M-46.28M-39.47M-39.47M4.14M-33.48M-17.27M
Income Tax Expenses1.45M32.00K19.75M41.70M34.43M29.18M43.33M-40.85M956.00K4.04M7.11M1.14M-16.25M-399.00K3.80M1.06M1.77M
Net Income1.32M60.71M53.42M126.95M113.06M110.99M57.28M91.22M14.02M19.87M-92.27M-46.28M56.00M-38.46M460.00K-33.48M-17.27M
Interest Expenses2.42M7.07M23.42M23.75M22.71M18.11M1.57M5.09M1.23M4.96M7.85M3.58M1.87M107.00K122.00K8.68M1.77M
Basic Shares Outstanding54.54M53.67M53.10M52.62M52.41M51.99M50.76M49.47M47.49M42.26M31.82M17.44M13.86M13.86M13.86M13.86M13.86M
Diluted Shares Outstanding55.51M61.68M54.36M53.69M53.82M54.10M53.30M51.71M51.16M50.58M31.85M17.44M13.86M13.86M13.86M13.86M13.86M
EBITDA90.04M153.44M129.19M212.40M180.42M151.51M107.67M56.62M21.77M-4.35M-83.68M-41.84M-36.73M-38.29M5.21M-23.69M-16.34M
EBITDA Margin14.82%23.00%22.28%40.82%45.94%37.05%35.63%26.33%15.07%-3.56%-696.25%-2,826.89%-4,573.47%-36,118.87%13.74%-266.48%-386.02%
EBIT5.18M67.81M96.60M192.40M170.19M158.29M102.19M55.46M16.20M28.87M-77.32M-41.57M41.62M-38.76M4.38M-23.75M-13.73M
EBIT Margin0.85%10.16%16.66%36.97%43.33%38.71%33.81%25.79%11.22%23.65%-643.29%-2,808.51%5,183.56%-36,561.32%11.55%-267.15%-324.28%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙